Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 276 results for "leerink swann llc"

Inogen PT Raised to $45.00 (INGN)
American Banking News

Leerink Swann Boosts Inogen Price Target to $45.00 (INGN)

Inogen (NASDAQ:INGN) had its price objective hosited by Leerink Swann from $40.00 to $45.00 in a report released on Tuesday. Leerink Swann currently has an outperform rating on the stock. Other equities research analysts have also recently issued ... SleekMoney, 3 weeks ago
Inogen PT Raised to $47.00 at Needham & Company LLC (INGN) American Banking News - Forex, 2 weeks ago
[x]  

Wageworks PT Set at $70.00 by Leerink Swann (WAGE)

Leerink Swann set a $70.00 target price on shares of Wageworks (NASDAQ:WAGE) stock in a research note issued on Tuesday. The firm currently has a a buy rating on the stock. Leerink Swann's price objective suggests a potential upside of 67.50% from ...
 SleekMoney2 weeks ago Leerink Swann Reiterates $70.00 Price Target for Wageworks (WAGE)  American Banking News - Forex2 weeks ago Brokerages Set $70.00 Price Target for Wageworks (NASDAQ:WAGE)  SleekMoney1 month ago

Alnylam Pharmaceuticals Given a $152.00 Price Target at Needham & Company LLC (ALNY)

Needham & Company LLC set a $152.00 price target on Alnylam Pharmaceuticals (NASDAQ:ALNY) in a research note issued to investors on Friday. The firm currently has a a buy rating on the stock. Shares of Alnylam Pharmaceuticals ( NASDAQ:ALNY ) ...
 SleekMoney2 weeks ago Intercept Pharmaceuticals Given a $500.00 Price Target by Needham & Company LLC Analysts (ICPT)  American Banking News2 months ago
SleekMoney

Boston Scientific Stock Rating Reaffirmed by Needham & Company LLC (BSX)

Boston Scientific (NYSE:BSX) s stock had its hold rating reissued by equities researchers at Needham & Company LLC in a research report issued on Wednesday. BSX has been the subject of a number of other recent research reports. Analysts at ...
 SleekMoney3 weeks ago Needham & Company LLC Reaffirms Hold Rating for Vertex Pharmaceuticals (VRTX)  SleekMoney3 weeks ago

Cerulean Pharma major shareholder Acquires $1,999,998.00 in Stock (CERU)

Cerulean Pharma (NASDAQ:CERU) major shareholder Cvf, Llc purchased 333,333 shares of the stock on the open market in a transaction that occurred on Tuesday, April 7th. The shares were purchased at an average cost of $6.00 per share, with a total ...
 SleekMoney1 month ago Insider Buying: Cvf, Llc Acquires 333,333 Shares of Cerulean Pharma Stock (CERU)  WKRB News1 month ago
WKRB News

Needham & Company LLC Analysts Give Dyax Corp. a $30.00 Price Target (DYAX)

Needham & Company LLC set a $30.00 target price on Dyax Corp. (NASDAQ:DYAX) in a report issued on Wednesday. The firm currently has a a buy rating on the stock. Several other analysts have also recently commented on the stock. Analysts at Leerink ...
 WKRB News1 month ago Dyax Corp. Given a $30.00 Price Target at Needham & Company LLC (DYAX)  SleekMoney1 month ago

Insider Selling: Orbimed Advisors Llc Sells 207,800 Shares of Intercept Pharmaceuticals Stock (ICPT)

Intercept Pharmaceuticals (NASDAQ:ICPT) Director Orbimed Advisors Llc sold 207,800 shares of the stock on the open market in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $274.41, for a total ...
 SleekMoney2 months ago Intercept Pharmaceuticals Director Jonathan Silverstein Sells 159,400 Shares (ICPT)  SleekMoney2 months ago

Alnylam Pharmaceuticals Earns Buy Rating from Canaccord Genuity (ALNY)

Canaccord Genuity restated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) in a research note issued to investors on Tuesday. The firm currently has a $160.00 price target on the biopharmaceutical company's stock. Alnylam ...
 SleekMoney1 hour ago Alnylam Pharmaceuticals Upgraded by TheStreet to Hold (ALNY)  American Banking News - Stock Ratings1 day ago Zacks Downgrades Alnylam Pharmaceuticals to Hold (ALNY)  American Banking News2 weeks ago Alnylam Pharmaceuticals Rating Lowered to Hold at Zacks (ALNY)  SleekMoney2 weeks ago
American Banking News - Forex

Insider Selling: Inogen Director Sells 86,889 Shares of Stock (INGN)

Inogen (NASDAQ:INGN) Director Timothy Petersen sold 86,889 shares of the company's stock on the open market in a transaction dated Friday, May 22nd. The shares were sold at an average price of $37.09, for a total transaction of $3,222,713.01. The ...
 American Banking News - Forex12 hours ago Insider Selling: Timothy Petersen Sells 134,300 Shares of Inogen Stock (INGN)  SleekMoney4 days ago Inogen Director Sells $2,203,164.45 in Stock (INGN)  SleekMoney6 days ago Inogen Director Timothy Petersen Sells 58,987 Shares (INGN)  American Banking News - Forex1 week ago

Wageworks Receives Buy Rating from Stifel Nicolaus (WAGE)

Wageworks (NASDAQ:WAGE)s stock had its buy rating reissued by equities research analysts at Stifel Nicolaus in a research note issued to investors on Saturday. They currently have a $55.00 price objective on the stock, down from their previous price ...
 American Banking News - Forex4 days ago Wageworks's Buy Rating Reaffirmed at Stifel Nicolaus (WAGE)  SleekMoney4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less